Safety profile of BG-12 (dimethyl fumarate) in relapsing remitting multiple sclerosis: long-term interim results from the ENDORSE extension study

被引：0
|
作者：
Phillips, J. T. [1 ]
Fox, R. J. [2 ]
Selmaj, K. [3 ]
Yang, M. [4 ]
Zhang, R. [4 ]
Novas, M. [4 ]
Sweetser, M. T. [4 ]
Viglietta, V. [4 ]
Gold, R. [5 ]
机构：
[1] Baylor Inst Immunol Res, Multiple Sclerosis Program, Dallas, TX USA
[2] Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH USA
[3] Med Univ Lodz, Lodz, Poland
[4] Biogen Idec Inc, Weston, MA USA
[5] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：457 / 457
页数：1
相关论文
共 50 条
  • [31] Efficacy of BG-12 (dimethyl fumarate) in relapsing remitting multiple sclerosis in patients from Europe: an integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Hutchinson, M.
    Fox, R. J.
    Bar-Or, A.
    Havrdova, E.
    Yang, M.
    Zhang, R.
    Viglietta, V.
    Sheikh, S. I.
    Gold, R.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 466 - 466
  • [32] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral BG-12 (Dimethyl Fumarate) in DEFINE and CONFIRM
    Meltzer, Leslie
    Selmaj, Krzysztof
    Gold, Ralf
    Fox, Robert
    Havrdova, Eva
    Giovannoni, Gavin
    Pace, Amy
    Novas, Mark
    Hotermans, Christophe
    Dawson, Katherine
    Phillips, J. Theodore
    NEUROLOGY, 2013, 80
  • [33] Rate of brain volume loss under long-term delayed-release dimethyl fumarate treatment in relapsing-remitting multiple sclerosis patients: results from the ENDORSE study
    Kappos, L.
    Fox, R. J.
    Gold, R.
    Arnold, D. L.
    Potts, J.
    Zhang, A.
    Kurukulasuriya, N. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 48 - 48
  • [34] An integrated analysis of safety and tolerability of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis from phase 2 and 3 placebo-controlled studies
    Phillips, J. T.
    Fox, R. J.
    Gold, R.
    Havrdova, E.
    Kappos, L.
    Raghupathi, K.
    Yuan, H.
    Viglietta, V.
    Sheikh, S. I.
    Dawson, K. T.
    Novas, M.
    Sweetser, M. T.
    Selmaj, K.
    JOURNAL OF NEUROLOGY, 2013, 260 : S75 - S75
  • [35] 3-Year Follow-up of Oral BG-12 (Dimethyl Fumarate) for Relapsing-Remitting Multiple Sclerosis (RRMS): Integrated Clinical Outcomes from the DEFINE, CONFIRM, and ENDORSE Studies
    Gold, R.
    Phillips, J. T.
    Bar-Or, A.
    Hutchinson, M.
    Kappos, L.
    Rana, J.
    Zhang, R.
    Yang, M.
    Viglietta, V.
    Sheikh, S. I.
    Fox, R. J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 932 - 932
  • [36] Gastrointestinal Tolerability Events in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Oral Bg-12 (Dimethyl Fumarate) in Define and Confirm
    Bar-Or, A.
    Selmaj, K.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Kurukulasuriya, N. C.
    Pace, A.
    Novas, M.
    Meltzer, L.
    Hotermans, C.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1840 - 1841
  • [37] Systematic Literature Review and Mixed Treatments Comparison of BG-12 (Dimethyl Fumarate) and Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
    Hutchinson, Michael
    Fox, Robert
    Havrdova, Eva
    Deniz, Baris
    Sarda, Sujata
    Jindal, Ramandeep
    Kapoor, Anuj
    NEUROLOGY, 2013, 80
  • [38] BG-12 effects on patient-reported outcomes in relapsing-remitting multiple sclerosis: results from the DEFINE study
    Kappos, L.
    Gold, R.
    Arnold, D.
    Bar-Or, A.
    Giovannoni, G.
    Selmaj, K.
    Tompkins, C.
    Agarwal, S.
    Dawson, K.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S488 - S489
  • [39] Safety and Tolerability of BG-12 (Dimethyl Fumarate) in Patients with Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of Phase 2 and 3 Placebo-Controlled Studies
    Phillips, J. Theodore
    Fox, Robert
    Gold, Ralf
    Havrdova, Eva
    Kappos, Ludwig
    Raghupathi, Kartik
    Yuan, Huixing
    Viglietta, Vissia
    Sheikh, Sarah
    Dawson, Katherine
    Novas, Mark
    Sweetser, Marianne
    Selmaj, Krzysztof
    NEUROLOGY, 2013, 80
  • [40] Clinical Efficacy and Safety of Oral Bg-12 (Dimethyl Fumarate) In Relapsing-Remitting Multiple Sclerosis (RRMS): An Integrated Analysis of the Phase 3 Define and Confirm Studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Havrdova, E.
    Selmaj, K.
    Kurukulasuriya, N. C.
    Yang, M.
    Raghupathi, K.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    Phillips, J. T.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1828 - 1828
12345